BioInItaly Investment Forum & Intesa Sanpaolo Start-Up Initiative is a yearly investment forum open to established biotech and nanobiotech companies, start-ups and projects from Italy but also from other European countries seeking for financial resources. In a unique end-to-end program, the applicants will benefit from coaching, networking and direct contact with international investors through a series of focused events. The initiative is aimed to provide the applicants with the competences, connections and access to potential Investors they need to go to market and scale.
Agenda BioInItaly Investment Forum 2015
JOIN US: email@example.com
Scientific Committee R. Palmisano
, coordinatore Genzyme F. Bartucci Novartis A. Contri Intesa Sanpaolo A. Mezzotero Atlante Ventures E. Ongini NicOx S. Panigone iBankers F. Sinigaglia Anabasis Pharma M. Varasi IEO M. Bonaccorso, project manager
BioInItaly Investment Forum & Intesa Sanpaolo Start-Up Initiative is designed as a yearlong, three-phase investment arena:
Phase 1 – Launch
Participants are invited to submit their ideas and proposals using the specific form downloadable from the web site of Assobiotec (www.assobiotec.it) and Innovhub SSI (www.innovhub.it). At the end of Phase 1, a maximum of 20 applicants are shortlisted for participating to Phase 2.
Phase 2 – Boot Camp and Investment Forum
The selected participants will attend a two-day boot camp session in Milan. The session will allow participants to benefit from extensive training to refine their business plans and craft presentations aimed specifically at the investor arena. This unique program will be run in cooperation with Silicon Valley angel investor network Maverick Angels. At the end of Phase 2 a session of deal line-up will take place in front of a group of investors and the selected finalists will be allowed to move forward in the Investment Forum which will be held in Milan on April 17-18, 2013.
Phase 3 – International Roadshow
Following the Investment Forum, some selected participants will be invited to take part in a series of Arena Meetings to be held in London, Frankfurt, Paris, San Francisco and New York during the course of 2013/2014. These unique networking events will provide contestants with the opportunity to pitch to an audience of top investors and receive detailed feedback following each meeting.
Applicants wishing to take part in this initiative must meet the following requirements:
• Contestants must have a company / project that fits within one of the following biotech and nanobiotech categories: health, agriculture, environment, industry, food, bioinformatics, energy
• Contestants must indicate their financial need
Participants of the previous edition will be considered only in presence of a new business plan.
The proposals submitted by contestants will be judged by a Selection Panel according to the following criteria:
Strength of Product / Technology
What are the strengths of the product and its technical standards? Is there a need for the proposed technology and does it offer an effective solution to a problem in the field? Is the product/technology original and disruptive?
Is the business model clear and sustainable? What is its capacity to monetize and what is the estimated time to market?
Market Size and Scalability
What are the size and attractiveness of the target market? Can the proposed technology or solution be deployed at a scale?
Barriers to Entry and Competitive Advantage
Is there a clear and sustainable competitive advantage in the proposed solution and are the barriers to entry strong enough to prevent competitors from penetrating the market?
What is the composition of the team? Is there a balance in terms of knowledge and expertise? What are their strengths and weaknesses? How strong is their overall commitment to the business?
Is the team’s business plan robust? What is their strategy for growing and financing the company in the medium term (3-5 years)?
At least 50% of the applicants will be selected considering as necessary condition their operative site in Italy or the intention to open it in Italy.
The Selection Panel will be composed by experienced and qualified professionals from the biotech and finance world.
The presentation that will be considered the most effective – according the rating assessment of the BioInItaly Commission and the Selection Panel – will be awarded the Corbelli Prize, consisting in the coverage by Assobiotec and Innovhub SSI of travel and accomodation expenses for one edition of the European road show (Frankfurt, London or Paris). Novartis Oncology Award
It will be assigned to the most promising oncology research project or startup, as evaluated by Novartis Oncology Italy among all applicants. The award will entail a trip to Basel Campus, one of Novartis’ leading worldwide oncology research center, with coverage of travel and accommodation expenses.